Rhea J. Posedel
CIK: 0001055117
Associated companies
Transaction History
| AEHR | ▼ Sell | Open Market | 5,973 | $836K | 8/14/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 8,413 | $1.1M | 8/12/2026 | View on chart |
| AEHR | ▲ Buy | Grant | 1,895 | $0 | 7/1/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 17,115 | $1.7M | 4/22/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 604 | $57K | 4/22/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 8,787 | $844K | 4/21/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 7,500 | $661K | 4/20/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 7,500 | $615K | 4/17/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 15,000 | $1.2M | 4/16/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 30,000 | $2.1M | 4/9/2026 | View on chart |
| AEHR | ▼ Sell | Open Market | 13,998 | $420K | 2/13/2026 | View on chart |
| AEHR | ▲ Buy | Option Exercise | 18,000 | $43K | 7/22/2025 | View on chart |
| AEHR | ▼ Sell | Open Market | 18,000 | $357K | 7/22/2025 | View on chart |
| AEHR | ▲ Buy | Grant | 10,575 | $0 | 7/2/2025 | View on chart |
| AEHR | ▼ Sell | Gift | 1,600 | $0 | 2/5/2025 | View on chart |
| AEHR | ▲ Buy | Grant | 10,589 | $0 | 7/11/2024 | View on chart |
| AEHR | ▲ Buy | Option Exercise | 18,000 | $71K | 2/6/2024 | View on chart |
| AEHR | ▼ Sell | Gift | 1,000 | $0 | 1/31/2024 | View on chart |
| AEHR | ▼ Sell | Gift | 725 | $0 | 11/6/2023 | View on chart |
| AEHR | ▲ Buy | Grant | 5,097 | $0 | 10/27/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 20,000 | $1.1M | 7/18/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 80,000 | $4.1M | 7/17/2023 | View on chart |
| AEHR | ▲ Buy | Grant | 5,000 | $0 | 7/11/2023 | View on chart |
| AEHR | ▲ Buy | Option Exercise | 18,000 | $30K | 5/17/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 18,000 | $522K | 5/17/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 20,000 | $658K | 1/23/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 20,000 | $698K | 1/23/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 20,000 | $618K | 1/20/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 20,000 | $638K | 1/20/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 19,600 | $586K | 1/13/2023 | View on chart |
| AEHR | ▼ Sell | Open Market | 400 | $12K | 1/11/2023 | View on chart |
| AEHR | ▲ Buy | Grant | 3,243 | $0 | 10/18/2022 | View on chart |
| AEHR | ▲ Buy | Grant | 5,000 | $0 | 10/18/2022 | View on chart |
| AEHR | ▲ Buy | Option Exercise | 18,000 | $38K | 4/19/2022 | View on chart |
| AEHR | ▼ Sell | Open Market | 25,000 | $623K | 11/3/2021 | View on chart |
| AEHR | ▼ Sell | Gift | 10,000 | $0 | 10/26/2021 | View on chart |
| AEHR | ▼ Sell | Gift | 20,000 | $0 | 10/25/2021 | View on chart |
| AEHR | ▲ Buy | Grant | 3,023 | $0 | 10/19/2021 | View on chart |
| AEHR | ▼ Sell | Open Market | 9,400 | $198K | 10/15/2021 | View on chart |
| AEHR | ▼ Sell | Open Market | 15,600 | $328K | 10/14/2021 | View on chart |
| AEHR | ▼ Sell | Open Market | 24,000 | $478K | 10/11/2021 | View on chart |
| AEHR | ▼ Sell | Open Market | 1,000 | $20K | 10/8/2021 | View on chart |
| AEHR | ▼ Sell | Open Market | 20,000 | $300K | 10/7/2021 | View on chart |
| AEHR | ▼ Sell | Open Market | 150,000 | $2.1M | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Aehr Test Systems Secures $6M Follow-On AI Order
Aehr Test Systems announced a $6 million follow-on order for its Sonoma production systems, destined for a major hyperscale customer's next-generation AI processor. This development highlights continued demand for the company's testing infrastructure in the high-performance computing sector. The stock is scheduled to report its first-quarter fiscal 2027 financial results on November 2, 2026.
Aehr Test Systems Secures $6M Follow-On AI Order. Aehr Test Systems announced a $6 million follow-on order for its Sonoma production systems, destined for a major hyperscale customer's next-generation AI processor. This development highlights continued demand for the company's testing infrastructure in the high-performance computing sector. The stock is scheduled to report its first-quarter fiscal 2027 financial results on November 2, 2026.